Reports
Reports
Sale
The global stretch marks treatment market size was valued at USD 2.66 billion in 2023, driven by the heightened prevalence of obesity. The market is anticipated to grow at a CAGR of 8.3% during the forecast period of 2024-2032 to achieve a value of USD 5.46 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on treatment, the topical products segment is predicted to occupy a considerable share in the global stretch marks treatment industry during the forecast period. This growth can be attributed to the heightened utilisation of topical products in the treatment of stretch marks caused by pale skin, pregnancy, and sudden weight gain and loss, among others. In addition, the easy accessibility to topical products such as oils and serums also contributes to its popularity among consumers. Meanwhile, the laser segment is expected to contribute to the market growth owing to its non-invasive and quick treatment properties. For instance, in 2018, Candela Corporation announced the FDA approval for their Vbeam Prima, an advanced 595 nm pulsed dye laser (PDL), which is expected to help with many skin conditions such as acne, scars, benign pigmented lesions, and stretch marks. Therefore, these factors are estimated to drive the market growth in the forecast period.
North America is predicted to possess a significant market share in the global stretch marks treatment industry. This can be attributed to the increased demand for stretch marks treatment in the region due to increased consciousness about cosmetics and fashion. In addition, the high disposable income and increased awareness of stretch marks treatment procedures are driving the market growth. Moreover, the growing rate of obesity in the region caused by the increasingly fat-laden diet is also a major factor in the growth of the industry. According to the 2020 statistics cited by Trust for America's Health, a non-profit organisation, adult obesity rate stands at 42.4%, which has increased by 26% since 2008. These factors are estimated to drive the market growth in the coming years.
Stretch marks, also known as striae, are off-coloured scars that appear in parallel bands on the body. These scars develop on the skin when it gets stretched and shrink quickly. The abrupt shrinking causes the collagen and elastin, which support our skin, to rupture, and as the skin heals, stretch marks appear. Moreover, an increase in the cortisone hormone, a hormone naturally produced by the adrenal glands, also causes stretch marks, as it reduces skin elasticity. These marks often affect the abdomen, buttocks, thighs, back, legs and breasts, among others. Abrupt weight gain and loss, pregnancy and puberty are some of the causes of stretch marks. In addition, stretch marks are not dangerous and can disappear over time. However, treatment may make them less noticeable more quickly.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
By treatment, the market is distributed into:
Among these, topical products can be segregated into oils and serum, creams, and lotions. While laser can be divided into fractional laser, pulse-dye laser, and others.
Based on end use, the market can be segmented into:
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The increasing focus on beauty and wellness is one of the major factors driving the growth of the stretch marks treatment industry. In addition, the growing prevalence of obesity is expected to further aid the market growth. According to the WHO statistics, more than 1.9 billion adults, 18 years and older, were overweight in 2016. Of these, over 650 million were obese. Furthermore, in 2019, an estimated 38.2 million children under 5 years of age were overweight or obese. The cases of obesity are increasing in urban households caused by the imbalance between the consumed sum of calories and the number of calories expended. In addition, the growing popularity of fast food among the younger population is leading to an increased consumption of high fat and high sugar content. Moreover, the rise of a sedentary working environment with little physical activities, increasing urbanisation, and the changing modes of transportation are significantly contributing to the growing rates of obesity. Due to obesity, the excess fat leads to stretching of the skin, causing stretch marks. These factors are expected to drive the market growth in the forecast period.
The report gives a detailed analysis of the following key players in the global stretch marks treatment market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model and SWOT analysis.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Treatment Type |
|
Breakup by Route of Administration |
|
Breakup by End User |
|
Breakup by Treatment Channel |
|
Breakup by Distribution Channel |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Stretch Marks Overview
3.1 Guidelines and Stages
3.2 Pathophysiology
3.3 Screening and Diagnosis
3.4 Treatment Pathway
4 Patient Profile
4.1 Patient Profile Overview
4.2 Patient Psychology and Emotional Impact Factors
4.3 Risk Assessment and Treatment Success Rate
5 Stretch Marks Epidemiology Analysis
5.1 Epidemiology Overview (2016-2031)
5.2 North America Stretch Marks Epidemiology (2016-2031)
5.3 Europe Stretch Marks Epidemiology (2016-2031)
5.4 Asia-Pacific Stretch Marks Epidemiology (2016-2031)
5.5 Latin America Stretch Marks Epidemiology (2016-2031)
5.6 Middle East & Africa Stretch Marks Epidemiology (2016-2031)
6 Global Stretch Marks Treatment Market Overview
6.1 Global Stretch Marks Treatment Market Historical Value (2017-2023)
6.2 Global Stretch Marks Treatment Market Forecast Value (2024-2032)
7 Global Stretch Marks Treatment Market Landscape
7.1 Global Stretch Marks Treatment: Developers Landscape
7.1.1 Analysis by Year of Establishment
7.1.2 Analysis by Company Size
7.1.3 Analysis by Region
7.2 Global Stretch Marks Treatment Product Landscape
7.2.1 Analysis by Treatment Type
7.2.2 Analysis by Route of Administration
7.2.3 Analysis by End User
8 Stretch Marks Treatment Challenges and Unmet Needs
8.1 Treatment Pathway Challenges
8.2 Compliance and Drop-Out Analysis
8.3 Awareness and Prevention Gaps
9 Cost of Treatment
10 Global Stretch Marks Treatment Market Dynamics
10.1 Market Drivers and Constraints
10.2 SWOT Analysis
10.3 Porter’s Five Forces Model
10.4 Key Demand Indicators
10.5 Key Price Indicators
10.6 Industry Events, Initiatives, and Trends
10.7 Value Chain Analysis
11 Global Stretch Marks Treatment Market Segmentation
11.1 Global Stretch Marks Treatment Market by Treatment Type
11.1.1 Market Overview
11.1.2 Topical Products
11.1.2.1 Creams
11.1.2.2 Ointments
11.1.2.3 Oils
11.1.2.4 Serums
11.1.2.5 Lotions
11.1.3 Lasers
11.1.3.1 Fractional Laser
11.1.3.2 Pulse-Dye Laser
11.1.3.3 Others
11.1.4 Microdermabrasion
11.1.5 Others
11.2 Global Stretch Marks Treatment Market by Route of Administration
11.2.1 Market Overview
11.2.2 Oral
11.2.3 Topical
11.2.4 Others
11.3 Global Stretch Marks Treatment Market by End User
11.3.1 Market Overview
11.3.2 Hospitals
11.3.3 Specialty Clinics
11.3.4 Homecare
11.3.5 Others
11.4 Global Stretch Marks Treatment Market by Treatment Channel
11.4.1 Market Overview
11.4.2 Public
11.4.3 Private
11.5 Global Stretch Marks Treatment Market by Distribution Channel
11.5.1 Market Overview
11.5.2 Hospital Pharmacy
11.5.3 Online Pharmacy
11.5.4 Retail Pharmacy
11.6 Global Stretch Marks Treatment Market by Region
11.6.1 Market Overview
11.6.2 North America
11.6.3 Europe
11.6.4 Asia Pacific
11.6.5 Latin America
11.6.6 Middle East and Africa
12 North America Stretch Marks Treatment Market
12.1 Market Share by Country
12.2 United States of America
12.3 Canada
13 Europe Stretch Marks Treatment Market
13.1 Market Share by Country
13.2 United Kingdom
13.3 Germany
13.4 France
13.5 Italy
13.6 Others
14 Asia Pacific Stretch Marks Treatment Market
14.1 Market Share by Country
14.2 China
14.3 Japan
14.4 India
14.5 ASEAN
14.6 Australia
14.7 Others
15 Latin America Stretch Marks Treatment Market
15.1 Market Share by Country
15.2 Brazil
15.3 Argentina
15.4 Mexico
15.5 Others
16 Middle East and Africa Stretch Marks Treatment Market
16.1 Market Share by Country
16.2 Saudi Arabia
16.3 United Arab Emirates
16.4 Nigeria
16.5 South Africa
16.6 Others
17 Regulatory Framework
17.1 Regulatory Overview
17.1.1 US FDA
17.1.2 EU EMA
17.1.3 INDIA CDSCO
17.1.4 JAPAN PMDA
17.1.5 Others
18 Patent Analysis
18.1 Analysis by Type of Patent
18.2 Analysis by Publication year
18.3 Analysis by Issuing Authority
18.4 Analysis by Patent Age
18.5 Analysis by CPC Analysis
18.6 Analysis by Patent Valuation
18.7 Analysis by Key Players
19 Grants Analysis
19.1 Analysis by year
19.2 Analysis by Amount Awarded
19.3 Analysis by Issuing Authority
19.4 Analysis by Grant Application
19.5 Analysis by Funding Institute
19.6 Analysis by NIH Departments
19.7 Analysis by Recipient Organization
20 Clinical Trials Analysis
20.1 Analysis by Trial Registration Year
20.2 Analysis by Trial Status
20.3 Analysis by Trial Phase
20.4 Analysis by Therapeutic Area
20.5 Analysis by Geography
21 Funding and Investment Analysis
21.1 Analysis by Funding Instances
21.2 Analysis by Type of Funding
21.3 Analysis by Funding Amount
21.4 Analysis by Leading Players
21.5 Analysis by Leading Investors
21.6 Analysis by Geography
22 Partnership and Collaborations Analysis
22.1 Analysis by Partnership Instances
22.2 Analysis by Type of Partnership
22.3 Analysis by Leading Players
22.4 Analysis by Geography
23 Supplier Landscape
23.1 Clarins
23.1.1 Financial Analysis
23.1.2 Product Portfolio
23.1.3 Demographic Reach and Achievements
23.1.4 Mergers and Acquisitions
23.1.5 Certifications
23.2 Laboratoires Expanscience
23.2.1 Financial Analysis
23.2.2 Product Portfolio
23.2.3 Demographic Reach and Achievements
23.2.4 Mergers and Acquisitions
23.2.5 Certifications
23.3 Merz Pharma
23.3.1 Financial Analysis
23.3.2 Product Portfolio
23.3.3 Demographic Reach and Achievements
23.3.4 Mergers and Acquisitions
23.3.5 Certifications
23.4 Candela Corporation
23.4.1 Financial Analysis
23.4.2 Product Portfolio
23.4.3 Demographic Reach and Achievements
23.4.4 Mergers and Acquisitions
23.4.5 Certifications
23.5 Cynosure LLC
23.5.1 Financial Analysis
23.5.2 Product Portfolio
23.5.3 Demographic Reach and Achievements
23.5.4 Mergers and Acquisitions
23.5.5 Certifications
23.6 basq NYC
23.6.1 Financial Analysis
23.6.2 Product Portfolio
23.6.3 Demographic Reach and Achievements
23.6.4 Mergers and Acquisitions
23.6.5 Certifications
23.7 E.T. Browne Drug Co., Inc.
23.7.1 Financial Analysis
23.7.2 Product Portfolio
23.7.3 Demographic Reach and Achievements
23.7.4 Mergers and Acquisitions
23.7.5 Certifications
23.8 Lumenis Be Ltd.
23.8.1 Financial Analysis
23.8.2 Product Portfolio
23.8.3 Demographic Reach and Achievements
23.8.4 Mergers and Acquisitions
23.8.5 Certifications
23.9 Bio-Oil
23.9.1 Financial Analysis
23.9.2 Product Portfolio
23.9.3 Demographic Reach and Achievements
23.9.4 Mergers and Acquisitions
23.9.5 Certifications
23.10 Concord Medisys
23.10.1 Financial Analysis
23.10.2 Product Portfolio
23.10.3 Demographic Reach and Achievements
23.10.4 Mergers and Acquisitions
23.10.5 Certifications
23.11 Helix BioMedix, Inc.
23.11.1 Financial Analysis
23.11.2 Product Portfolio
23.11.3 Demographic Reach and Achievements
23.11.4 Mergers and Acquisitions
23.11.5 Certifications
23.12 The Boppy Company LLC
23.12.1 Financial Analysis
23.12.2 Product Portfolio
23.12.3 Demographic Reach and Achievements
23.12.4 Mergers and Acquisitions
23.12.5 Certifications
23.13 Cult Beauty
23.13.1 Financial Analysis
23.13.2 Product Portfolio
23.13.3 Demographic Reach and Achievements
23.13.4 Mergers and Acquisitions
23.13.5 Certifications
23.14 Casmara
23.14.1 Financial Analysis
23.14.2 Product Portfolio
23.14.3 Demographic Reach and Achievements
23.14.4 Mergers and Acquisitions
23.14.5 Certifications
23.15 Weleda
23.15.1 Financial Analysis
23.15.2 Product Portfolio
23.15.3 Demographic Reach and Achievements
23.15.4 Mergers and Acquisitions
23.15.5 Certifications
23.16 Mama Mio
23.16.1 Financial Analysis
23.16.2 Product Portfolio
23.16.3 Demographic Reach and Achievements
23.16.4 Mergers and Acquisitions
23.16.5 Certifications
23.17 Dermaclara
23.17.1 Financial Analysis
23.17.2 Product Portfolio
23.17.3 Demographic Reach and Achievements
23.17.4 Mergers and Acquisitions
23.17.5 Certifications
23.18 Strialite
23.18.1 Financial Analysis
23.18.2 Product Portfolio
23.18.3 Demographic Reach and Achievements
23.18.4 Mergers and Acquisitions
23.18.5 Certifications
23.19 Bayer AG
23.19.1 Financial Analysis
23.19.2 Product Portfolio
23.19.3 Demographic Reach and Achievements
23.19.4 Mergers and Acquisitions
23.19.5 Certifications
23.20 Helix BioMedix
23.20.1 Financial Analysis
23.20.2 Product Portfolio
23.20.3 Demographic Reach and Achievements
23.20.4 Mergers and Acquisitions
23.20.5 Certifications
24 Global Stretch Marks Treatment Market- Distribution Model (Additional Insight)
24.1 Overview
24.2 Potential Distributors
24.3 Key Parameters for Distribution Partner Assessment
25 Key Opinion Leaders (KOL) Insights (Additional Insight)
26 Company Competitiveness Analysis (Additional Insight)
26.1 Very Small Companies
26.2 Small Companies
26.3 Mid-Sized Companies
26.4 Large Companies
26.5 Very Large Companies
27 Payment Methods (Additional Insight)
27.1 Government Funded
27.2 Private Insurance
27.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
In 2023, the global market for stretch marks treatment attained a value of USD 2.66 billion.
The market is anticipated to grow at a CAGR of 8.3% during the forecast period of 2024-2032 to reach a value of USD 5.46 billion by 2032.
The major drivers of the industry, such as the increased prevalence of stretch marks worldwide, rising awareness of stretch marks prevention and treatment procedures, rising urbanisation, growing disposable income, and increasing focus on aesthetics and beauty, are expected to aid the market growth.
The key market trends guiding the growth of the industry include the heightened prevalence of obesity.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The significant treatments available in the market are topical products, laser, and others.
The significant end use segments include hospital and clinics and home use.
The major players in the industry are Alliance Pharmaceuticals PLC, Clarins Group, Candela Corporation, Helix BioMedix, Inc., and HRA Pharma, SA, among others.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.